偶发未破裂颅内动脉瘤治疗的长期结局:322例队列研究
该单中心回顾性队列纳入322例患者共431个偶发未破裂颅内动脉瘤,其中356个接受治疗,评估严重不良事件、复发率和动脉瘤闭塞状态。中位随访48.1个月显示围手术期并发症率7.0%,90天永久残疾率1.4%,弹簧圈治疗动脉瘤再通率20%,晚期出现支架血栓形成和动脉瘤破裂致死各1例。结论提示需长期影像随访,理想随访至少5年。
要点
- 偶发未破裂动脉瘤治疗后可发生极晚期并发症,包括延迟性破裂。
- 弹簧圈治疗的动脉瘤约20%发生再通,需长期影像监测。
- 非动脉瘤性死亡率不可忽视,年死亡率为0.97%。
核心结论
- 偶发未破裂颅内动脉瘤治疗可能与极晚期并发症相关,包括延迟性破裂。
- 约20%经弹簧圈治疗的动脉瘤发生再通,需长期影像监测。
- 该人群非动脉瘤性死亡率不可忽视,建议至少5年长期随访评估。
研究设计与样本
- 回顾性单中心队列研究,纳入322例患者共431个偶发未破裂颅内动脉瘤。
- 其中356个动脉瘤在2011年1月至2020年7月间接受治疗。
- 治疗方式包括弹簧圈栓塞、弹簧圈加支架、夹闭、血流导向支架和Woven EndoBridge装置。
- 临床和影像随访持续至2024年5月,平均随访48.1个月。
主要发现
- 患者平均年龄53.1岁,女性占71%,95%动脉瘤位于前循环。
- 围手术期并发症率为7.0%,90天永久残疾率为1.4%。
- 晚期并发症包括1例致命性支架血栓形成和1例致命性动脉瘤破裂。
- 1例患者因新发动脉瘤发生蛛网膜下腔出血,另1例从已知未治疗动脉瘤出血。
- 弹簧圈治疗动脉瘤再通率为20%,7例患者(2.2%)失访。
关键数值与推荐
- 围手术期并发症率7.0%,90天永久残疾率1.4%。
- 弹簧圈治疗动脉瘤再通率20%。
- 非动脉瘤性年死亡率为0.97%。
- 失访率2.2%(7例患者)。
临床怎么用
- 对偶发未破裂颅内动脉瘤治疗后应进行长期影像随访,理想至少5年。
- 弹簧圈治疗患者需重点监测再通,再通率约20%。
- 临床随访中需关注极晚期并发症及非动脉瘤性死亡风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the long-term outcomes associated with treating incidental unruptured intracranial aneurysms (UIAs). MATERIALS AND METHODS: This retrospective single-center cohort study included 322 patients with 431 UIAs, of which 356 were treated between January 2011 and July 2020. Treatment modalities included coiling, coiling with stenting, clipping, flow diverter stents, and the Woven EndoBridge device. Outcomes were assessed in terms of serious adverse events, recurrence rates, and aneurysm occlusion status based on the modified Raymond-Roy classification (MRRC). RESULTS: The mean patient age was 53.1 years, with a predominance of females (71%). Most aneurysms (95%) were located in the anterior circulation. Clinical and radiological follow-up continued through May 2024 with a mean follow-up of 48.1 months. The perioperative complication rate was 7.0%, with 1.4% of patients experiencing permanent disability at 90 days. Late complications (occurring more than 12 months post-treatment) included one fatal stent thrombosis and one fatal aneurysmal rupture. Additionally, one patient suffered a subarachnoid hemorrhage (SAH) due to a de novo aneurysm, and another bled from a known but untreated aneurysm. The annual non-aneurysmal mortality rate was 0.97%. Recanalization occurred in 20% of aneurysms treated with coils. Seven patients (2.2%) were lost to follow-up. CONCLUSION: Treatment of UIAs may be associated with very late complications, including delayed rupture. Approximately 20% of aneurysms treated with coils recanalized, necessitating long-term imaging surveillance. Non-aneurysmal mortality in this population is also non-negligible. These findings highlight the need for long-term evaluation of UIA treatment outcomes, ideally over a minimum follow-up period of five years.
引用
- Aubertin M, Guédon A, Fantoni M, et al. Long-term outcomes and lessons learned from treating incidental cerebral aneurysms: a cohort study of 322 patients. Acta Neurochir (Wien). 2026. PMID: 42118366. doi:10.1007/s00701-026-06873-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。